Novartis Pharma Stein is a finished-dose manufacturer based in Switzerland. It appears in 87 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and NAFDAC (NG). Its GMP standing is certified by EMA, ANVISA (Brazil) and EAEU_EEC, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 6 December 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| STEIN, United Arab Emirates | Not on file |
| STEIN, Switzerland | Not on file |
| Switzerland, Switzerland | 3002653483 |
| Stein AG, Switzerland | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Diclofenac Diethylamine | SFDA (Saudi Arabia) | 1 |
| Pasireotide Diaspartate | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 48 | None |
| MINSA (CR) | 13 | None |
| NAFDAC (NG) | 10 | 1 |
| DIGEMAPS (DO) | 8 | None |
| NPRA (MY) | 3 | None |
| MCAZ (ZW) | 2 | None |
| EMA | None | 6 |
| ANVISA (Brazil) | None | 2 |
| EAEU_EEC | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Novartis Pharma Stein comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.